The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3
Tomotake Kanai(Niigata University), Naoto Endo(Niigata University)
Cited by 37
Related Papers
Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
|Archives of Osteoporosis|2012|360
Effect of temozolomide on the viability of musculoskeletal sarcoma cells
|Oncology Letters|2015|6